Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
about
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaGenetics and biology of pancreatic ductal adenocarcinomaInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyCrosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancerCancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Optimal population of FoxP3+ T cells in tumors requires an antigen priming-dependent trafficking receptor switchLosartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumorsT cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Challenges and future perspectives of T cell immunotherapy in cancerPancreatic ductal adenocarcinoma: a review of immunologic aspects.The role of inflammatory cells in fostering pancreatic cancer cell growth and invasionNaringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α -Galactosylceramide-Stimulated Natural Killer T Cells.Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor developmentCancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.The polarization of immune cells in the tumour environment by TGFbeta.Role of immune cells in pancreatic cancer from bench to clinical application: An updated reviewAutoimmunity as a double agent in tumor killing and cancer promotion.Lymphatics: at the interface of immunity, tolerance, and tumor metastasis.The immune network in pancreatic cancer development and progression.Immunological landscape and immunotherapy of hepatocellular carcinoma.Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans.Association between autoimmune pancreatitis and malignancy.L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.TGF-β Family Signaling in Tumor Suppression and Cancer Progression.Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cellsInterleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cellsRetinal pigment epithelial cells induce foxp3(+) regulatory T cells via membrane-bound TGF-β.B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion.Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma.Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models.
P2860
Q24629841-C4237559-799A-4157-B09E-C22828FA0ED4Q26765438-3AEACE44-3F22-47FC-ACCF-BCF3A9F82A2CQ27008625-60087D75-644D-47D2-BFC7-1324030E18D5Q28084851-58710AF1-1204-44DD-8BFA-71889A140EBCQ33753714-03416783-2473-416C-B2EB-984A05A37DFCQ34073958-F22EB478-3530-4628-B0EC-DE0A91F4995CQ34084756-69F14042-E924-4E00-B528-A3C14CB2115EQ34146406-5447D38D-22D8-4362-BBD7-CE3656E1CE1CQ34163525-B47C5313-BCC4-4E81-B332-6EE4760A5D79Q34294055-668B8721-7D99-4CC1-9B47-A994C48D3757Q35570260-3DB12709-9BA3-4E92-B2E9-7F769EE80713Q35632079-152591D6-08F9-4EC6-9DCC-4D3CA4B44C95Q35739397-0EF84219-CED3-4CF8-BF94-35E9220E5981Q35843507-29376708-3630-4E82-AE08-9DE02E728716Q35870682-DC0CBF74-3840-41B6-AB96-499BC7729C81Q36202213-063A2330-C367-43C0-A637-5AA997836786Q36758301-C61F2ADB-5179-473E-844B-15D5032637A5Q36957222-D02B1E99-B013-4E01-A2A2-6C6D20F400AEQ37002737-C7DD8B5E-B86C-433D-88A3-1B5509E1F607Q37017085-80658480-984C-493D-B4F5-EC4A9E9B1223Q37055402-83AB4E50-6652-4E35-81D8-F12D11BC1F19Q37199750-777D3A69-E92A-4D92-A464-F3BB844C44D6Q37308216-0FC576CD-B966-4E62-9B7C-D7DE94A5BC7BQ37454364-092FCAA6-ED18-4E69-BE7C-A403D9A0CF29Q37606102-862E70C3-D7CF-415D-9EF8-AA37BE40DC66Q37642271-A89FFD40-6EF9-44BA-AF99-FA27D83611D8Q37875904-6D40D603-880C-4A08-B572-59925C05F490Q38121412-A2F52814-038C-4FD7-A8A1-35139834DB65Q38611895-23B12B34-FF74-4F25-B397-7369EE8C69C8Q38924558-D4EC0943-5AB8-430B-B96F-41C760925DCDQ38983899-46C78EBF-729A-4519-98EC-D3D153D680D4Q39003009-62B580A6-3AD0-4462-A264-64294347513CQ39155158-918A5ABA-E39C-424C-A479-05B579BBD361Q40056618-92FBFCA6-11B9-4300-B1CA-2857B9B917B2Q42130225-4C730EEB-459A-480B-AB47-EF1FA566C631Q42290425-A5FCB42C-195D-49F9-92D4-816F41FEB41FQ42871808-59CFF43F-91A7-425E-B99D-D717743FF7AEQ43418649-2A054417-4443-4060-BA0E-16A8FA543A08Q46628241-D7F85C7A-10BB-4FB9-9946-D627674EF2ABQ47094540-6151FBD4-6DAE-47F4-8466-3872F8244A45
P2860
Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@en
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@nl
type
label
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@en
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@nl
prefLabel
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@en
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@nl
P2093
P2860
P1476
Tumor-derived TGF-beta mediate ...... rine model of pancreas cancer.
@en
P2093
Brian A Belt
David C Linehan
Justin W Larson
Marcus C Tan
Peter S Goedegebuure
Timothy J Eberlein
Tricia A Moo-Young
William G Hawkins
P2860
P356
10.1097/CJI.0B013E318189F13C
P577
2009-01-01T00:00:00Z